feed,title,long_url,short_url
Benzinga,AstraZeneca's Tagrisso Doublet Therapy Shows 49% Response Rate In Lung Cancer Setting,https://benzinga.com/general/biotech/22/08/28392268/astrazenecas-tagrisso-doublet-therapy-shows-49-response-rate-in-lung-cancer-setting,https://bit.ly/3P8bQ7Z
